ArticleJournal of pharmacy & bioallied sciences2025
Efficacy of Emblica Officinalis and Curcumin Longa, Two Significant Herbal Antioxidants, in the Management of OSMF: A Comparative Cross-sectional Study.
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Curcumin and Its Derivatives as Anticancer Agents in Head and Neck Cancer: Molecular Mechanisms and Preclinical Evidence.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Oral submucous fibrosis (OSMF) is a persistent, potentially cancerous condition that affects 6.42 out of every 1000 people in South Asia. It causes burning sensation, limited mouth opening, and fibrosis. This study compares the efficacy of Emblica officinalis and Curcumin longa, two potent herbal antioxidants, in managing OSMF symptoms. Materials and Methods: Sixty clinically diagnosed OSMF patients were equally divided into Groups A and B who received Emblica officinalis and Curcumin longa respectively (i.e., twice daily for 2 months). Data was analyzed using the Chi-square and Student's paired Results: Group A showed greater reduction in oral burning (Visual Analogue Scale scores), while Group B exhibited significant improvement in mouth opening. Discussion: Curcumin longa was more effective in improving mouth opening and reducing fibrous bands, for treating OSMF-related structural and functional deficits. Emblica officinalis offered more relief from the burning sensation, indicating its importance in symptomatic therapy. Conclusion: A combination therapy may offer a more holistic approach. Future research should explore nanoparticle formulations of Curcumin longa and Emblica officinalis to enhance their therapeutic potential in OSMF and fibrosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.